Friday 4th July 2003 |
Text too small? |
Chairman Jim Guthrie said from Dunedin yesterday that the death on Monday of director and significant shareholder Howard Paterson follows closely after the cancer diagnosis and subsequent treatment of founder Dr Corran McLachlan.
"Directors, shareholders and staff are devastated by Howard's sudden death," he said.
"Corrie is undergoing treatment and is not expected to be on deck for some time."
Mr Guthrie said the best way they could "keep faith with the vision of Mr Paterson and Dr McLachlan was to continue with the work they began."
Mr Guthrie said A2 Corporation's European directors would be travelling to New Zealand shortly to help the board review the company's future options.
"We are fortunate that we can call on the services of some very talented people here and overseas," he said. "Despite these recent tragic occurrences A2 Corporation is strongly positioned to build upon the foundation laid down by Howard and Corrie."
A2 Corporation was founded in 2000 to commercialise research relating to milk proteins. Its licensees have recently released a range of milk products on the New Zealand and Australian markets.
No comments yet
AGL - Change in Senior Management
Devon Funds Morning Note - 01 May 2024
Rick Christie to step-aside as a non-executive director
CHI - New customer contract to upgrade Marsden Point
Synlait announces changes to Board of Directors
May 1st Morning Report
Devon Funds Morning Note - 30 April 2024
New Rural Advocacy Hub to be launched at Fieldays 2024
Serko signs five-year partnership renewal with Booking.com
NPH - 2024 Half Year Results Announcement Date